DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Cardiology Homepage

Virginia med school to offer portable ultrasound with 12-lead ECG technology Viewing the heart and measuring electrical activity

Megha Prasad SCAI-Women in Innovations announces winner of the Complex and High-Risk Interventional Procedures CHIP Fellowship

New tool images amount of plaque present in atherosclerosis Enables accurate evaluation of drug treatment

Elsevier touts new study validating use of STATdx solution Reduced diagnostic errors by as much as 37 percent

NIH grants over $1 million to development of non-contrast imaging approaches Will be used to diagnose peripheral arterial disease

Pre-activating cardiac catherization labs benefits EMS STEMI patients on arrival Saves critical minutes and can bypass typical ED protocols

Apple Watch can monitor heart rhythms with FDA approval Detects atrial fibrillation and can tell if you've taken a sudden fall

Keith D. Dawkins InnovHeart elects chairman of the board

Jeffrey S. Brown Endologix appoints chief operations officer

Bioengineers create virtual 3D heart with AI Could provide a boost to the treatment of atrial fibrillation

A new tool may predict the
risk of 30-day readmissions among
TAVR patients

New tool predicts readmission among TAVR patients

by John R. Fischer , Staff Reporter
Thirty day readmission rates for TAVR patients may soon become predictable events among providers equipped with a new risk scoring tool.

That’s what researchers behind a study on the device claimed in their findings at the Society of Cardiovascular Angiography and Interventions 2018 Scientific Sessions, elaborating on its ability to score a patient’s risk of being readmitted following TAVR procedures.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"The creation of this tool and the results of the study are very assuring because it allows for better understanding of how patients should be managed peri-TAVR,” lead author Sahil Khera, a clinical and research fellow of interventional cardiology at Massachusetts General Hospital, said in a statement. “By recognizing patients at higher risk of readmission, we can guide post discharge care coordination and improve transitions of care to decrease readmission, improve quality of life, reduce healthcare costs and ultimately impact mortality rates.”

More than five million Americans are diagnosed with heart valve disease annually. Of those that undergo TAVR, nearly 15-20 percent are readmitted within 30 days, affecting positive outcomes, and together, racking up more than $40 billion in hospital costs annually.

The tool provides clinicians and medical professionals with a score to determine which patients are most at risk to be readmitted within 30 days. Probability scores are based on complex survey methods, hierarchical regression and the "rms" library.

The study examined 39,305 patients from the Nationwide Readmissions Database who underwent endovascular TAVR from January 2013 to September 2015 with researchers performing an international calibration with bootstrapping.

The final risk tool took into consideration chronic kidney disease, end stage renal disease on dialysis, anemia, chronic lung disease, chronic liver disease, atrial fibrillation, lengths of stay for more than five days, acute kidney injury, and discharge disposition.

Researchers recorded a score of 212 associated, with a readmission rate of more than 30 percent. Of the initial number of patients, 6,380 patients were readmitted within 30 days, a rate of 16.2 percent. The c-statistic of the model was 0.63.

"Use of the simple risk tool will allow the entire care team to quantify readmission risk and enhance our ability to provide personalized transitional care to hopefully mitigate this risk," said co-author Sammy Elmariah, director of interventional structural heart disease at Massachusetts General Hospital, in a statement.

The authors hope to begin using and incorporating the tools in hospital EMRs nationwide.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED